Bill Anderson

Bayer Extends CEO’s Term Through 2029

Bayer's Supervisory Board has unanimously decided to extend the contract with the company's CEO, Bill Anderson, until March 31, 2029.

News

Bill Anderson to Be Bayer CEO from June 1

Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player Bayer has announced the appointment of a new CEO to succeed embattled incumbent Werner Baumann — a year before the end of the current chief executive’s regular term.

Top-Feature

Brenntag SE

API Manufacturing

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Bayer AG

Bill Anderson

Bayer Extends CEO’s Term Through 2029

Bill Anderson to Be Bayer CEO from June 1

Top-Feature

Brenntag Downsizes Management Board, Retains Both Divisions

Anchored in Sustainability

Leading Transformation

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Driving Sustainability Through Collaboration

Leading the way. Driving results.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Advanced Recycling Conference 2025: New Paths to the Circular Economy

API Manufacturing

Interview

Leading Transformation

Newsletter & e-edition